Medicamen Biotech Limited — Others, 11-02-2025: Appointment

Medicamen Biotech has announced a board meeting, approving the appointment of Mr. Chandan Kumar as Chief Financial Officer and Key Managerial Personnel, effective immediately. Mr. Kumar brings over 15 years of expertise in accounting, taxation, and auditing, previously serving as Head of Accounts & Audit at Brawn Laboratories. This appointment signals a strategic enhancement in the company's financial management, potentially leading to improved operational efficiency and governance. From an investor perspective, this could present a positive outlook as the company strengthens its leadership team, which may foster greater transparency and drive growth initiatives.